Effects of disruption of heat shock genes on susceptibility of Escherichia coli to fluoroquinolones -: art. no. 16

被引:53
作者
Yamaguchi, Y
Tomoyasu, T
Takaya, A
Morioka, M
Yamamoto, T [1 ]
机构
[1] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Microbiol & Mol Genet, Chiba 2638522, Japan
[2] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130033, Japan
关键词
D O I
10.1186/1471-2180-3-16
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: It is well known that expression of certain bacterial genes responds rapidly to such stimuli as exposure to toxic chemicals and physical agents. It is generally believed that the proteins encoded in these genes are important for successful survival of the organism under the hostile conditions. Analogously, the proteins induced in bacterial cells exposed to antibiotics are believed to affect the organisms' susceptibility to these agents. Results: We demonstrated that Escherichia coli cells exposed to levofloxacin ( LVFX), a fluoroquinolone (FQ), induce the syntheses of heat shock proteins and RecA. To examine whether the heat shock proteins affect the bactericidal action of FQs, we constructed E. coli strains with mutations in various heat shock genes and tested their susceptibility to FQs. Mutations in dnaK, groEL, and ion increased this susceptibility; the ion mutant exhibited the greatest effects. The increased susceptibility of the ion mutant was corroborated by experiments in which the gene encoding the cell division inhibitor, SulA, was subsequently disrupted. SulA is induced by the SOS response and degraded by the Lon protease. The findings suggest that the hypersusceptibility of the ion mutant to FQs could be due to abnormally high levels of SulA protein resulting from the depletion of Lon and the continuous induction of the SOS response in the presence of FQs. Conclusion: The present results show that the bactericidal action of FQs is moderately affected by the DnaK and GroEL chaperones and strongly affected by the Lon protease. FQs have contributed successfully to the treatment of various bacterial infections, but their widespread use and often misuse, coupled with emerging resistance, have gradually compromised their utility. Our results suggest that agents capable of inhibiting the Lon protease have potential for combination therapy with FQs.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 23 条
[1]   CELL-DIVISION INHIBITORS SULA AND MINCD PREVENT FORMATION OF THE FTSZ RING [J].
BI, E ;
LUTKENHAUS, J .
JOURNAL OF BACTERIOLOGY, 1993, 175 (04) :1118-1125
[2]  
BUKAU B, 1990, EMBO J, V9, P4024
[3]   PROTEINS REQUIRED FOR ULTRAVIOLET-LIGHT AND CHEMICAL MUTAGENESIS - IDENTIFICATION OF THE PRODUCTS OF THE UMUC LOCUS OF ESCHERICHIA-COLI [J].
ELLEDGE, SJ ;
WALKER, GC .
JOURNAL OF MOLECULAR BIOLOGY, 1983, 164 (02) :175-192
[4]   PHYSICAL INTERACTION BETWEEN HEAT-SHOCK PROTEINS DNAK, DNAJ, AND GRPE AND THE BACTERIAL HEAT-SHOCK TRANSCRIPTION FACTOR-SIGMA(32) [J].
GAMER, J ;
BUJARD, H ;
BUKAU, B .
CELL, 1992, 69 (05) :833-842
[6]   Clinical applications of quinolones [J].
Hooper, DC .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1998, 1400 (1-3) :45-61
[7]   Synergistic roles of Hs1VU and other ATP-dependent proteases in controlling in vivo turnover of sigma(32) and abnormal proteins in Escherichia coli [J].
Kanemori, M ;
Nishihara, K ;
Yanagi, H ;
Yura, T .
JOURNAL OF BACTERIOLOGY, 1997, 179 (23) :7219-7225
[8]   Small heat shock proteins, IbpA and IbpB, are involved in resistances to heat and superoxide stresses in Escherichia coli [J].
Kitagawa, M ;
Matsumura, Y ;
Tsuchido, T .
FEMS MICROBIOLOGY LETTERS, 2000, 184 (02) :165-171
[9]   GROEL AND DNAK GENES OF ESCHERICHIA-COLI ARE INDUCED BY UV IRRADIATION AND NALIDIXIC-ACID IN AN HTPR+-DEPENDENT FASHION [J].
KRUEGER, JH ;
WALKER, GC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (05) :1499-1503
[10]   Quinolone-resistant mutants of Escherichia coli DNA topoisomerase IV parC gene [J].
Kumagai, Y ;
Kato, J ;
Hoshino, K ;
Akasaka, T ;
Sato, K ;
Ikeda, H .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (03) :710-714